Copyright Reports & Markets. All rights reserved.

Global IV and Oral Iron Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 IV and Oral Iron Drugs Market Overview

    • 1.1 Product Overview and Scope of IV and Oral Iron Drugs
    • 1.2 Classification of IV and Oral Iron Drugs by Types
      • 1.2.1 Global IV and Oral Iron Drugs Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global IV and Oral Iron Drugs Revenue Market Share by Types in 2018
      • 1.2.3 Oral Iron Drug
      • 1.2.4 IVIron Drugs
    • 1.3 Global IV and Oral Iron Drugs Market by Application
      • 1.3.1 Global IV and Oral Iron Drugs Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Nephrology
      • 1.3.3 OBGYN
      • 1.3.4 Surgeries
      • 1.3.5 Gastroenterology
      • 1.3.6 Oncology
      • 1.3.7 Heart failure (HF)
    • 1.4 Global IV and Oral Iron Drugs Market by Regions
      • 1.4.1 Global IV and Oral Iron Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) IV and Oral Iron Drugs Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) IV and Oral Iron Drugs Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) IV and Oral Iron Drugs Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) IV and Oral Iron Drugs Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) IV and Oral Iron Drugs Status and Prospect (2014-2024)
    • 1.5 Global Market Size of IV and Oral Iron Drugs (2014-2024)

    2 Company Profiles

    • 2.1 Daiichi Sankyo Company
      • 2.1.1 Business Overview
      • 2.1.2 IV and Oral Iron Drugs Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Daiichi Sankyo Company IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi
      • 2.2.1 Business Overview
      • 2.2.2 IV and Oral Iron Drugs Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Allergan
      • 2.3.1 Business Overview
      • 2.3.2 IV and Oral Iron Drugs Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Allergan IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Vifor Pharma
      • 2.4.1 Business Overview
      • 2.4.2 IV and Oral Iron Drugs Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Vifor Pharma IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pharmacosmos
      • 2.5.1 Business Overview
      • 2.5.2 IV and Oral Iron Drugs Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pharmacosmos IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Akebia Therapeutics
      • 2.6.1 Business Overview
      • 2.6.2 IV and Oral Iron Drugs Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Akebia Therapeutics IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 AZAD Pharma
      • 2.7.1 Business Overview
      • 2.7.2 IV and Oral Iron Drugs Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 AZAD Pharma IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 AOP Orphan Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 IV and Oral Iron Drugs Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 AOP Orphan Pharmaceuticals IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 AMAG Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 IV and Oral Iron Drugs Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 AMAG Pharmaceuticals IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Shield Therapeutics
      • 2.10.1 Business Overview
      • 2.10.2 IV and Oral Iron Drugs Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Shield Therapeutics IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Sunny Pharmaceutical
      • 2.11.1 Business Overview
      • 2.11.2 IV and Oral Iron Drugs Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Sunny Pharmaceutical IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Cirondrugs
      • 2.12.1 Business Overview
      • 2.12.2 IV and Oral Iron Drugs Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Cirondrugs IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Salveo Lifecare
      • 2.13.1 Business Overview
      • 2.13.2 IV and Oral Iron Drugs Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Salveo Lifecare IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 MEDICE
      • 2.14.1 Business Overview
      • 2.14.2 IV and Oral Iron Drugs Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 MEDICE IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Pfizer
      • 2.15.1 Business Overview
      • 2.15.2 IV and Oral Iron Drugs Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Pfizer IV and Oral Iron Drugs Revenue, Gross Margin and Market Share (2017-2018)

    3 Global IV and Oral Iron Drugs Market Competition, by Players

    • 3.1 Global IV and Oral Iron Drugs Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 IV and Oral Iron Drugs Players Market Share
      • 3.2.2 Top 10 IV and Oral Iron Drugs Players Market Share
    • 3.3 Market Competition Trend

    4 Global IV and Oral Iron Drugs Market Size by Regions

    • 4.1 Global IV and Oral Iron Drugs Revenue and Market Share by Regions
    • 4.2 North America IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 4.3 Europe IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 4.5 South America IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    5 North America IV and Oral Iron Drugs Revenue by Countries

    • 5.1 North America IV and Oral Iron Drugs Revenue by Countries (2014-2019)
    • 5.2 USA IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 5.3 Canada IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    6 Europe IV and Oral Iron Drugs Revenue by Countries

    • 6.1 Europe IV and Oral Iron Drugs Revenue by Countries (2014-2019)
    • 6.2 Germany IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 6.3 UK IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 6.4 France IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 6.5 Russia IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 6.6 Italy IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific IV and Oral Iron Drugs Revenue by Countries

    • 7.1 Asia-Pacific IV and Oral Iron Drugs Revenue by Countries (2014-2019)
    • 7.2 China IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 7.3 Japan IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 7.4 Korea IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 7.5 India IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    8 South America IV and Oral Iron Drugs Revenue by Countries

    • 8.1 South America IV and Oral Iron Drugs Revenue by Countries (2014-2019)
    • 8.2 Brazil IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue IV and Oral Iron Drugs by Countries

    • 9.1 Middle East and Africa IV and Oral Iron Drugs Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 9.3 UAE IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa IV and Oral Iron Drugs Revenue and Growth Rate (2014-2019)

    10 Global IV and Oral Iron Drugs Market Segment by Type

    • 10.1 Global IV and Oral Iron Drugs Revenue and Market Share by Type (2014-2019)
    • 10.2 Global IV and Oral Iron Drugs Market Forecast by Type (2019-2024)
    • 10.3 Oral Iron Drug Revenue Growth Rate (2014-2024)
    • 10.4 IVIron Drugs Revenue Growth Rate (2014-2024)

    11 Global IV and Oral Iron Drugs Market Segment by Application

    • 11.1 Global IV and Oral Iron Drugs Revenue Market Share by Application (2014-2019)
    • 11.2 IV and Oral Iron Drugs Market Forecast by Application (2019-2024)
    • 11.3 Nephrology Revenue Growth (2014-2019)
    • 11.4 OBGYN Revenue Growth (2014-2019)
    • 11.5 Surgeries Revenue Growth (2014-2019)
    • 11.6 Gastroenterology Revenue Growth (2014-2019)
    • 11.7 Oncology Revenue Growth (2014-2019)
    • 11.8 Heart failure (HF) Revenue Growth (2014-2019)

    12 Global IV and Oral Iron Drugs Market Size Forecast (2019-2024)

    • 12.1 Global IV and Oral Iron Drugs Market Size Forecast (2019-2024)
    • 12.2 Global IV and Oral Iron Drugs Market Forecast by Regions (2019-2024)
    • 12.3 North America IV and Oral Iron Drugs Revenue Market Forecast (2019-2024)
    • 12.4 Europe IV and Oral Iron Drugs Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific IV and Oral Iron Drugs Revenue Market Forecast (2019-2024)
    • 12.6 South America IV and Oral Iron Drugs Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa IV and Oral Iron Drugs Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Description

      Scope of the Report:
      The global IV and Oral Iron Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of IV and Oral Iron Drugs.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the IV and Oral Iron Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the IV and Oral Iron Drugs market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Daiichi Sankyo Company
      Sanofi
      Allergan
      Vifor Pharma
      Pharmacosmos
      Akebia Therapeutics
      AZAD Pharma
      AOP Orphan Pharmaceuticals
      AMAG Pharmaceuticals
      Shield Therapeutics
      Sunny Pharmaceutical
      Cirondrugs
      Salveo Lifecare
      MEDICE
      Pfizer

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Oral Iron Drug
      IVIron Drugs

      Market Segment by Applications, can be divided into
      Nephrology
      OBGYN
      Surgeries
      Gastroenterology
      Oncology
      Heart failure (HF)
      Buy now